Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

Clinical trial NCT06957366 · RECRUITING

Trial details

NCT number: NCT06957366
Sponsor: McMaster University
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Atrial Fibrillation (AF)VTE

Start date: 2025-04-01
Primary completion: 2027-12-31
Enrollment: 920

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.